Fig 1.
Flowchart for patient selection.
eGFR, estimated glomerular filtration rate; KDIGO, Kidney Disease Improving Global Outcomes; CKD, chronic kidney disease; AKI, acute kidney injury.
Table 1.
Descriptive data of study participants and comparison between AKI and non-AKI groups.
Table 2.
Frequency of potentially nephrotoxic drugs used concomitantly with vancomycin in non-critically ill patients (n = 98).
Fig 2.
Comparative analysis of initial vancomycin trough levels according development of AKI.
AKI, acute kidney injury.
Table 3.
Model of regression of Poisson (with robust covariance matrix) for the factors related with acute kidney injury in non-critically patients receiving vancomycin.